Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Acq. announced
Appointed director
CC transcript
Life Technologies Corp (LIFE) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/01/2012 PRN Life Technologies Names Senior Vice President of External Affairs & Corporate Communications
09/27/2012 PRN FDA Clears Life Technologies' OpTmizer™ T-Cell Growth Medium for Use in Clinical Trials
09/19/2012 PRN Pathogenica and Life Technologies EMEA Partner to Control Hospital Acquired Infections
09/19/2012 PRN Pathogenica und Life Technologies EMEA schließen Partnerschaft zur Bekämpfung von Krankenhausinfektionen
09/19/2012 PRN Pathogenica y Life Technologies EMEA se unen en el control de las infecciones adquiridas en el hospital
09/17/2012 PRN Life Technologies establece nuevo estándar mundial para pruebas criminales forenses con la presentación del kit GlobalFiler™
09/17/2012 PRN A Life Technologies estabelece novo padrão mundial para testes de medicina forense criminalística com o lançamento do kit GlobalFiler™
09/17/2012 PRN Life Technologies Sets New Worldwide Standard for Criminal Forensic Testing with Introduction of GlobalFiler™ Kit
08/28/2012 PRN Life Technologies to Present at UBS Global Life Sciences Conference
04/24/2012 PRN Life Technologies to Build Additional $20 Million State of the Art Cell Culture Facility in Scotland
04/04/2012 PRN Life Technologies to Accelerate Adoption of Next-Generation Sequencing in HLA Through Key Partnerships
02/21/2012 PRN Life Technologies to Present at Barclays Capital Global Healthcare Conference
02/06/2012 PRN AltheaDx Certified as Authorized Customer Service Provider by Ion Torrent
02/02/2012 PRN Ronnie Andrews Joins Life Technologies as President, Medical Sciences
01/13/2012 PRN Life Technologies Announces Redemption of 1.5% Convertible Senior Notes Due 2024
01/10/2012 PRN Carnegie Mellon Will Tap Advanced Computer Methods to Help Doctors Make Sense of Their Patients' DNA
01/10/2012 PRN Life Technologies Introduces the Benchtop Ion Proton™ Sequencer; Designed to Decode a Human Genome in One Day for $1,000
01/09/2012 PRN Ion Torrent Delivers on Unparalleled Speed, Simplicity and Scalability Enabled by Semiconductor Technology
01/05/2012 PRN Life Technologies Receives AFNOR Validation for Tests Designed to Detect Listeria Contamination in Food Samples
01/01/2012 PRN Number of Ion Community Users Triples, Spurred by Open Access to DNA Sequencing Protocols and Analysis Software
12/16/2011 PRN Genomsequenzierung fördert Forschung auf dem Gebiet der weit verbreiteten Volkskrankheiten in Frankreich.
12/16/2011 PRN La secuenciación del genoma ayuda a la investigación de las enfermedades públicas en Francia
10/12/2011 PRN Ion Torrent Gets Better Faster With 4th Qtr New Product Releases
10/04/2011 PRN Life Technologies Sets 3rd Quarter 2011 Earnings Release Date for Tuesday, October 25, 2011
09/22/2011 PRN Life Technologies und Quidel erzielen Vertriebs- und Vermarktungsvereinbarung über Diagnostik-Assays in Europa
09/22/2011 PRN Life Technologies firma un acuerdo con Quidel para distribuir y comercializar ensayos de diagnosis en Europa
09/22/2011 PRN Life Technologies Signs Agreement with Quidel to Distribute and Commercialize Diagnostic Assays in Europe
09/16/2011 PRN Life Technologies Applauds Signing of Patent Reform Bill
07/12/2011 PRN Life Technologies Introduces First and Only USDA-Approved Real-Time PCR Test to Detect Swine Influenza Virus
06/06/2011 PRN Life Technologies Develops Fast and Accurate Test to Detect Europe's Deadly E. coli
05/31/2011 PRN Ion Torrent Ships New RNA Sequencing Application as Fast, Easy, Affordable Alternative to Microarrays
05/26/2011 PRN Life Technologies Simplifies, Organizes and Speeds Analysis of Genomic Data Through Launch of New LifeScope Bioinformatics Software
05/17/2011 PRN Life Technologies and ProBioGen AG Announce Freedom™ Cell Line Development Royalty-Free Kits To Advance Early Stage Biologic Drug Production
05/11/2011 PRN Life Technologies Announces Redemption of 3.25% Convertible Senior Notes Due 2025
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy